KAVISH PATIDAR to Prognosis
This is a "connection" page, showing publications KAVISH PATIDAR has written about Prognosis.
Connection Strength
0.706
-
Controversies in terlipressin and transplantation in the United States: How do we MELD the two? Liver Transpl. 2024 Jul 01; 30(7):753-759.
Score: 0.115
-
Clinical characteristics and prognosis of hospitalized patients with moderate alcohol-associated hepatitis. Liver Int. 2024 01; 44(1):241-249.
Score: 0.112
-
Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study. Liver Transpl. 2024 03 01; 30(3):244-253.
Score: 0.110
-
The prognostic impact of acute kidney injury recovery patterns in critically ill patients with cirrhosis. Liver Transpl. 2023 03 01; 29(3):246-258.
Score: 0.106
-
Admission Factor V Predicts Transplant-Free Survival in Acute Liver Failure. Dig Dis Sci. 2021 02; 66(2):619-627.
Score: 0.087
-
No Association Between Quick Sequential Organ Failure Assessment and Outcomes of Patients With Cirrhosis and Infections. Clin Gastroenterol Hepatol. 2017 11; 15(11):1803-1804.
Score: 0.072
-
Impact of acute kidney injury response on survival and liver transplant rates in hospitalized patients with cirrhosis awaiting liver transplantation: Results from the HRS-HARMONY consortium. Liver Transpl. 2024 Nov 01; 30(11):1106-1115.
Score: 0.029
-
Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosis. Liver Transpl. 2025 Jan 01; 31(1):24-31.
Score: 0.029
-
Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium. Aliment Pharmacol Ther. 2024 Sep; 60(6):778-786.
Score: 0.029
-
Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease. Liver Int. 2016 Apr; 36(4):572-9.
Score: 0.016